Biotech · Private company

UCB BIOSCIENCES, Inc.

Track this companyFree. Adds UCB BIOSCIENCES, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials191 recruiting or active

Pipeline programs23From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline23

BrivaracetamPhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
Carbamazepine-Controlled ReleasePhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
Certolizumab PegolPhase 3 · Axial SpondyloarthritisClinicalTrials.gov · fetched Nov 12, 2026
Certolizumab PegolPhase 3 · Axial SpondyloarthrithisClinicalTrials.gov · fetched Nov 12, 2026
Certolizumab Pegol (CZP)Phase 3 · Polyarticular-course Juvenile Idiopathic Arthritis (JIA)ClinicalTrials.gov · fetched Nov 12, 2026
fenfluraminePhase 3 · Dravet SyndromeClinicalTrials.gov · fetched Nov 12, 2026
fenfluramine hydrochloridePhase 3 · Rett SyndromeClinicalTrials.gov · fetched Nov 12, 2026
LacosamidePhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
LacosamidePhase 3 · Epilepsy With Partial-onset SeizuresClinicalTrials.gov · fetched Nov 12, 2026
Lacosamide Oral SolutionPhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
Lacosamide TabletPhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
Lasosamide Oral SolutionPhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
CDP6038 (olokizumab)Phase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
doxecitine and doxribtiminePhase 2 · Thymidine Kinase 2 DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
Blood sampling from infantPhase 1 · Axial Spondyloarthritis (AxSpA)ClinicalTrials.gov · fetched Nov 12, 2026
Blood sampling from motherPhase 1 · Axial Spondyloarthritis (AxSpA)ClinicalTrials.gov · fetched Nov 12, 2026
Blood sampling from umbilical cordPhase 1 · Axial Spondyloarthritis (AxSpA)ClinicalTrials.gov · fetched Nov 12, 2026
bupropionPhase 1 · Healthy Study ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Certolizumab PegolPhase 1 · Axial Spondyloarthritis (AxSpA)ClinicalTrials.gov · fetched Nov 12, 2026
fenfluramine HClPhase 1 · Healthy Study ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
metforminPhase 1 · Healthy Study ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
midazolamPhase 1 · Healthy Study ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
CimziaCrohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials19

A Phase 3 Study of Fenfluramine Hydrochloride in Rett SyndromePHASE3 · RECRUITING · started Jul 14, 2026ClinicalTrials.gov NCT07503444 · fetched Nov 12, 2026
A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study ParticipantsPHASE1 · COMPLETED · started Dec 4, 2024ClinicalTrials.gov NCT06679413 · fetched Nov 12, 2026
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet SyndromePHASE3 · COMPLETED · started May 21, 2024ClinicalTrials.gov NCT06118255 · fetched Nov 12, 2026
An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 DeficiencyPHASE2 · COMPLETED · started Jul 5, 2019ClinicalTrials.gov NCT03845712 · fetched Nov 12, 2026
Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.PHASE2_PHASE3 · COMPLETED · started May 30, 2017ClinicalTrials.gov NCT02710890 · fetched Nov 12, 2026
UCB Cimzia Pregnancy Follow-up StudyTERMINATED · started Nov 1, 2016ClinicalTrials.gov NCT02775656 · fetched Nov 12, 2026
Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of ASPHASE3 · COMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02552212 · fetched Nov 12, 2026
Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic SeizuresPHASE3 · COMPLETED · started Aug 3, 2015ClinicalTrials.gov NCT02408549 · fetched Nov 12, 2026
Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to PlaceboPHASE3 · COMPLETED · started Jul 1, 2015ClinicalTrials.gov NCT02505542 · fetched Nov 12, 2026
Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset SeizuresPHASE3 · COMPLETED · started Jun 5, 2015ClinicalTrials.gov NCT02477839 · fetched Nov 12, 2026
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic MedicationsPHASE3 · COMPLETED · started Apr 1, 2015ClinicalTrials.gov NCT02408523 · fetched Nov 12, 2026
A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset SeizuresPHASE3 · COMPLETED · started Aug 13, 2014ClinicalTrials.gov NCT01964560 · fetched Nov 12, 2026
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the PlacentaPHASE1 · COMPLETED · started Jan 1, 2014ClinicalTrials.gov NCT02019602 · fetched Nov 12, 2026
Pediatric Arthritis Study of Certolizumab PegolPHASE3 · COMPLETED · started Mar 8, 2012ClinicalTrials.gov NCT01550003 · fetched Nov 12, 2026
Brivaracetam Safety and Efficacy Follow-up Study in Subjects With EpilepsyPHASE3 · COMPLETED · started May 11, 2011ClinicalTrials.gov NCT01339559 · fetched Nov 12, 2026
Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and OlderPHASE3 · COMPLETED · started Apr 1, 2011ClinicalTrials.gov NCT01243177 · fetched Nov 12, 2026
Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056PHASE2 · TERMINATED · started Mar 7, 2011ClinicalTrials.gov NCT01296711 · fetched Nov 12, 2026
An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With EpilepsyPHASE2 · COMPLETED · started Dec 9, 2009ClinicalTrials.gov NCT00938912 · fetched Nov 12, 2026
SECURE, the Cimzia ® Crohn's Disease Post-Marketing RegistryCOMPLETED · started Jan 30, 2009ClinicalTrials.gov NCT00844285 · fetched Nov 12, 2026